{"pub_date": "2016-01-14T00:00:00Z", "subsection_name": null, "lead_paragraph": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "print_page": "1", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "POLLACK", "firstname": "Andrew", "role": "reported"}], "original": "By ANDREW POLLACK"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 398, "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "398", "xlarge": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"print_headline": "The Patient&#8217;s Sales Pitch ", "main": "Hemophilia Patient or Drug Seller? Dual Role Creates Ethical Quandary"}, "source": "The New York Times", "blog": [], "word_count": "1254", "web_url": "http://www.nytimes.com/2016/01/14/business/hemophilia-patient-or-drug-seller-dual-role-creates-ethical-quandary.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "_id": "569694b938f0d865e6c34836", "abstract": "Increasing number of hemophilia drug makers and specialty pharmacies are employing patients and their relatives to gain sales advantage and increase revenue; ethical issues are raised. ", "keywords": [{"rank": "1", "name": "subject", "value": "Hemophilia", "is_major": "Y"}, {"rank": "11", "name": "organizations", "value": "Novo Nordisk A/S", "is_major": "N"}, {"rank": "12", "name": "organizations", "value": "Baxalta Inc.", "is_major": "N"}, {"rank": "2", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Conflicts of Interest", "is_major": "Y"}, {"rank": "4", "name": "subject", "value": "Blood", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Ethics and Official Misconduct", "is_major": "N"}, {"rank": "6", "name": "organizations", "value": "Hemophilia of North Carolina", "is_major": "N"}, {"rank": "7", "name": "organizations", "value": "National Hemophilia Foundation", "is_major": "N"}, {"rank": "8", "name": "organizations", "value": "MedfusionRx LLC", "is_major": "N"}, {"rank": "9", "name": "organizations", "value": "Bayer AG", "is_major": "N"}, {"rank": "10", "name": "organizations", "value": "Pfizer Inc", "is_major": "N"}]}